Citigroup’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,100
| Closed | -$3K | – | 5186 |
|
|
2018
Q3 | $3K | Sell |
1,100
-32,620
| -97% | -$89K | ﹤0.01% | 4902 |
|
|
2018
Q2 | $124K | Buy |
33,720
+30,549
| +963% | +$112K | ﹤0.01% | 3278 |
|
|
2018
Q1 | $11K | Buy |
3,171
+934
| +42% | +$3.24K | ﹤0.01% | 4466 |
|
|
2017
Q4 | $7K | Buy |
2,237
+2,234
| +74,467% | +$6.99K | ﹤0.01% | 4605 |
|
|
2017
Q3 | $0 | Sell |
3
-4,908
| -100% | – | ﹤0.01% | 4983 |
|
|
2017
Q2 | $45K | Buy |
4,911
+16
| +0.3% | +$147 | ﹤0.01% | 3641 |
|
|
2017
Q1 | $52K | Sell |
4,895
-2,120
| -30% | -$22.5K | ﹤0.01% | 3655 |
|
|
2016
Q4 | $59K | Buy |
+7,015
| New | +$59K | ﹤0.01% | 4092 |
|